Chimera Investment (NYSE:CIM - Get Free Report) had its target price dropped by Keefe, Bruyette & Woods from $16.50 to $15.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a "market perform" rating on the real estate investment trust's stock. Keefe, Bruyette & Woods' price objective points to a potential upside of 6.65% from the company's current price.
CIM has been the subject of several other research reports. Royal Bank Of Canada raised Chimera Investment to a "moderate buy" rating in a research report on Friday, March 14th. UBS Group raised Chimera Investment from a "neutral" rating to a "buy" rating and raised their price target for the stock from $11.50 to $15.00 in a research report on Wednesday, May 14th. Finally, Wall Street Zen raised Chimera Investment from a "hold" rating to a "buy" rating in a research report on Thursday, May 15th. Two research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, Chimera Investment presently has an average rating of "Moderate Buy" and a consensus price target of $15.50.
View Our Latest Stock Analysis on CIM
Chimera Investment Stock Performance
Shares of CIM stock traded down $0.08 during trading hours on Thursday, reaching $14.07. 439,167 shares of the company's stock were exchanged, compared to its average volume of 567,977. The company has a market cap of $1.14 billion, a P/E ratio of 9.38 and a beta of 1.74. The company's 50 day moving average is $13.53 and its two-hundred day moving average is $13.45. Chimera Investment has a 1 year low of $9.85 and a 1 year high of $16.89. The company has a debt-to-equity ratio of 3.93, a current ratio of 3.70 and a quick ratio of 3.70.
Chimera Investment (NYSE:CIM - Get Free Report) last issued its earnings results on Thursday, May 8th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.03. Chimera Investment had a return on equity of 7.25% and a net margin of 25.12%. The business had revenue of $69.22 million during the quarter, compared to the consensus estimate of $72.07 million. Equities research analysts anticipate that Chimera Investment will post 1.57 EPS for the current fiscal year.
Institutional Investors Weigh In On Chimera Investment
Several hedge funds have recently made changes to their positions in the business. Voya Investment Management LLC boosted its holdings in Chimera Investment by 9.7% in the first quarter. Voya Investment Management LLC now owns 36,786 shares of the real estate investment trust's stock valued at $472,000 after acquiring an additional 3,250 shares during the last quarter. Strs Ohio acquired a new position in Chimera Investment in the first quarter valued at $194,000. Empowered Funds LLC boosted its holdings in Chimera Investment by 12.9% in the first quarter. Empowered Funds LLC now owns 21,322 shares of the real estate investment trust's stock valued at $274,000 after acquiring an additional 2,430 shares during the last quarter. Great Lakes Advisors LLC boosted its holdings in Chimera Investment by 50.5% in the first quarter. Great Lakes Advisors LLC now owns 45,031 shares of the real estate investment trust's stock valued at $578,000 after acquiring an additional 15,108 shares during the last quarter. Finally, Caxton Associates LLP acquired a new position in Chimera Investment in the first quarter valued at $1,167,000. Institutional investors and hedge funds own 48.44% of the company's stock.
Chimera Investment Company Profile
(
Get Free Report)
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
See Also
Before you consider Chimera Investment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chimera Investment wasn't on the list.
While Chimera Investment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
